To determine the mechanisms underlying these effects, Th2 polarized splenocytes (Th2-SPCs) and Th2 cloned cells (D10) from mice were treated with MSSM-002, and demonstrated significantly decreased proliferation, IL-4 and IL-5 secretion, and increased IFN- production [94]
Not suitable for individuals taking blood-thinning medication such as warfarin, those with hypotension, or those with autoimmune conditions unless advised by a healthcare practitioner
This group also showed improvements in MMSE scores and physical fitness (46)
Applicability of Therapeutic Opportunities from MASLD to MetALD and ALD The approach of using medications for MASLD to MetALD/ALD is currently under investigation worldwide, demonstrating that this concept is not limited to GLP-1 therapies
Measure Treatment Response Glucose and Hemoglobin A1C can show changes in glycemic control
Annual Review of Microbiology